Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc. (MDGL) — Form SCHEDULE 13D/A: Ownership over 5% (active) (amendment)
About this filing
Madrigal Pharmaceuticals Inc. (MDGL) filed Form SCHEDULE 13D/A (ownership over 5% (active) (amendment)) with the SEC on Nov 6, 2026. A Schedule 13D reports an investor owning more than 5% of the company who may seek to influence it.
Key facts
- Document
- —
More MDGL filings
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 144
Filed Nov 6, 2026
- 10-Q
Filed Nov 3, 2026
- 8-K
Filed Nov 3, 2026
- 144
Filed Sep 28, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.